CUE vs PG · rev $9.3M vs P/E 25, rev $84.28B
Cue Biopharma (CUE) versus Procter & Gamble Company (PG) — a side-by-side from cached financials, not a winner call.
Cue Biopharma (CUE) is a biotechnology company listed on US.
Procter & Gamble Company (PG) is a household & personal products company listed on US. It is led by Jon Moeller.
Latest reported CUE revenue for 2024-12-31 was $9.3M. Net income was -$40.7M. Revenue was up 69.2% from 2023-12-31 to 2024-12-31. CUE currently screens at market cap $59.5M.
Latest reported PG revenue for 2025-06-30 was $84.28B. Net income was $15.97B. PG currently screens at market cap $373.53B and trailing P/E 25.3.
CUE currently screens at market cap $59.5M. PG currently screens at market cap $373.53B and trailing P/E 25.3.
Not investment advice. Open the CUE and PG stock pages for the full models.
Not investment advice.